Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Lignoceric ceramide (CAS 34435-05-7)

0.0(0)
Write a reviewAsk a question

Alternate Names:
N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-tetracosanamide
Application:
Lignoceric ceramide is a naturally occuring ceramide
CAS Number:
34435-05-7
Molecular Weight:
650.1
Molecular Formula:
C42H83NO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Lignoceric ceramide, characterized by its long-chain lignoceric acid (a saturated fatty acid with 24 carbon atoms) amide-linked to a sphingosine base, is a critical component of the lipid matrix in the stratum corneum of the skin, as well as part of the complex lipid composition in the nervous system. This ceramide plays a significant role in maintaining the barrier function and structural integrity of cell membranes, particularly in the epidermis, where it contributes to moisture retention and protection against environmental factors. In research, lignoceric ceramide has been used to study the biomechanical properties of cell membranes and lipid layers, offering insights into the role of specific ceramides in cell signaling and membrane stability. Its presence affects the viscosity and phase behavior of lipid bilayers, which are crucial for cellular processes like vesicle formation, fusion, and the proper functioning of membrane-bound enzymes and receptors. Additionally, investigations into lignoceric ceramide′s interactions with other lipid species help explain the mechanisms by which lipid composition can influence cellular communication and metabolic regulation. Such studies are vital for understanding the biochemical pathways that govern cell physiology and the maintenance of cellular homeostasis under various physiological conditions.


Lignoceric ceramide (CAS 34435-05-7) References

  1. Sphingomyelinase and ceramide analogs induce contraction and rises in [Ca(2+)](i) in canine cerebral vascular muscle.  |  Zheng, T., et al. 2000. Am J Physiol Heart Circ Physiol. 278: H1421-8. PMID: 10775118
  2. Characterization of a new member of the fatty acid-binding protein family that binds all-trans-retinol.  |  Vogel, S., et al. 2001. J Biol Chem. 276: 1353-60. PMID: 11022035
  3. Separation and characterisation of sphingoceramides by high-performance liquid chromatography-electrospray ionisation mass spectrometry.  |  Camera, E., et al. 2004. J Sep Sci. 27: 971-6. PMID: 15352714
  4. An obligate role for membrane-associated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils.  |  Sitrin, RG., et al. 2011. Am J Respir Cell Mol Biol. 44: 205-12. PMID: 20378749
  5. Profiling the Essential Nature of Lipid Metabolism in Asexual Blood and Gametocyte Stages of Plasmodium falciparum.  |  Gulati, S., et al. 2015. Cell Host Microbe. 18: 371-81. PMID: 26355219
  6. Serum sphingolipid level in psoriatic patients with obesity.  |  Kozłowska, D., et al. 2019. Postepy Dermatol Alergol. 36: 714-721. PMID: 31998000
  7. Metabolomics of sleep disorders in HIV: a narrative review.  |  Balthazar, M., et al. 2020. Sleep Breath. 24: 1333-1337. PMID: 32198720
  8. Lipid profile disturbances may predispose psoriatic patients to liver dysfunction.  |  Kozłowska, D., et al. 2021. Postepy Dermatol Alergol. 38: 310-318. PMID: 34408599
  9. The Role of Sphingolipids in the Pathogenesis of Psoriasis.  |  Matwiejuk, M., et al. 2022. Metabolites. 12: PMID: 36557209

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Lignoceric ceramide, 5 mg

sc-202694
5 mg
$130.00